ALLMedicine™ Hepatorenal Syndrome Center

Jun 7th, 2021 - Hepatorenal syndrome (HRS) is a severe complication of cirrhosis with high mortality, which necessitates accurate clinical decision. However, studies on prognostic factors and scoring systems to predict overall survival of HRS are not enough. Mean...

May 25th, 2021 - Acute kidney injury (AKI) in a patient with cirrhosis has high short-term mortality. Midodrine has shown promising results in the treatment of AKI-hepatorenal syndrome (HRS-AKI). To compare midodrine and albumin versus albumin alone for the second...

May 24th, 2021 - Hepatorenal syndrome (HRS) is a devastating complication of advanced liver disease associated with high mortality. Despite having been described as a clinical syndrome more than 60 years ago, options for the treatment of HRS remain very limited. M...

May 22nd, 2021 - Leptospirosis is a common tropical febrile illness which may manifest with the hepatorenal syndrome and systemic hemorrhagic manifestations. Pituitary apoplexy is a rare but life-threatening condition characterized by a hemorrhage within the pitui...

May 12th, 2021 - Urinary neutrophil gelatinase-associated lipocalin (NGAL) has shown promise in differentiating acute tubular necrosis (ATN) from other types of acute kidney injuries (AKIs) in cirrhosis, particularly hepatorenal syndrome (HRS). However, NGAL is no...

Jul 16th, 2010 - EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.|2010| ,|therapeutic use,diagnosis,etiology,therapy,diagnosis,etiology,therapy,therapeutic use,diagnosis,etiol...

Jun 7th, 2021 - Hepatorenal syndrome (HRS) is a severe complication of cirrhosis with high mortality, which necessitates accurate clinical decision. However, studies on prognostic factors and scoring systems to predict overall survival of HRS are not enough. Mean...

May 25th, 2021 - Acute kidney injury (AKI) in a patient with cirrhosis has high short-term mortality. Midodrine has shown promising results in the treatment of AKI-hepatorenal syndrome (HRS-AKI). To compare midodrine and albumin versus albumin alone for the second...

May 24th, 2021 - Hepatorenal syndrome (HRS) is a devastating complication of advanced liver disease associated with high mortality. Despite having been described as a clinical syndrome more than 60 years ago, options for the treatment of HRS remain very limited. M...

May 22nd, 2021 - Leptospirosis is a common tropical febrile illness which may manifest with the hepatorenal syndrome and systemic hemorrhagic manifestations. Pituitary apoplexy is a rare but life-threatening condition characterized by a hemorrhage within the pitui...

May 12th, 2021 - Urinary neutrophil gelatinase-associated lipocalin (NGAL) has shown promise in differentiating acute tubular necrosis (ATN) from other types of acute kidney injuries (AKIs) in cirrhosis, particularly hepatorenal syndrome (HRS). However, NGAL is no...

Mar 3rd, 2021 - NEW YORK (Reuters Health) - Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome (HRS-1), although not without potentially serious side effects. The study, published i...

Jul 15th, 2020 - The US Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval to terlipressin for the treatment of hepatorenal syndrome type 1, a seve...

Jul 15th, 2020 - The US Food and Drug Administration's (FDA's) Cardiovascular and Renal Drugs Advisory Committee narrowly recommended, by an 8-7 vote, that the agency grant marketing approval to terlipressin for the treatment of hepatorenal syndrome type 1, a seve...

Jul 5th, 2020 - In this case, the patient's postprocedural course was characterized initially by worsening liver failure, elevated intra-abdominal pressures, and confusion. He eventually progressed to frank encephalopathy, hepatorenal syndrome, and pneumonia. Ult...

Jun 11th, 2020 - Takeaway Terlipressin is the most commonly prescribed vasoconstrictor for hospitalised patients with hepatorenal syndrome-acute kidney injury (HRS-AKI) in the UK, consistent with current guidelines. Initiation of terlipressin in patients with less...